As illustrated in Figure 2 and depicted in detail in Table S2, SATB2-low/absent CRCs were significantly enriched in higher pT/pN/pM and combined UICC-stages, right-sided tumours, carcinomas with lymphatic and blood vessel invasion as well as in tumours with positive margins (p < 0.001, respectively). This evidence concerns the gene SATB2 and neoplasm.